Zymeworks’ Scott Platshon sells 15,292 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Zymeworks Inc. EVP, Chief Business Officer Scott Platshon had 37,037 common shares issued when one-third of his restricted stock units vested on November 18, 2026. He also sold 15,292 shares at a weighted average price of $24.95.
The sale covered required tax withholding and other applicable fees under mandatory “sell to cover” provisions and was not discretionary. His RSU position was 74,074 following the transaction. No Rule 10b5-1 plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit F4, F5 | 37,037 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 37,037 | $0.00 | $0.00 |
| Sale | Common Stock F2, F3 | 15,292 | $24.95 | $382K |
Footnotes (5)
- F1. Represents shares of common stock issued upon vesting of one third of the restricted stock units ("RSUs") granted on November 18, 2025.
- F2. Represents shares of common stock sold to cover tax withholding obligations and other applicable fees in connection with the vesting of RSUs pursuant to mandatory "sell to cover" provisions contained in the Reporting Person's applicable RSU grant agreement, and does not represent a discretionary sale by the Reporting Person. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees.
- F3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.88 to $25.05, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- F4. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of common stock.
- F5. RSUs granted November 18, 2025; vest in three equal annual instalments beginning November 18, 2026.
Key Figures
Key Terms
restricted stock units technical
sell to cover financial
weighted average price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.